Evidence map›Paper›PMID 36435449›Full record

ArticleOphthalmology. Glaucoma

Diagnostic Accuracy of Frequency-Doubling Technology and the Moorfields Motion Displacement Test for Glaucoma.

Quintin R Richardson, Rajesh S Kumar, Balu Ramgopal, Mahalakshmi V Rackenchath, Sathi Devi A V, Suria S Mannil, Sriharsha Nagaraj, Caitlin A Moe, Dionna M Wittberg, Kieran S O'Brien and 3 more

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology. Glaucoma. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Quintin R RichardsonFrancis I. Proctor Foundation, University of California, San Francisco, California.
Rajesh S KumarNarayana Nethralaya Eye Hospital, Bangalore, India; Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Balu RamgopalNarayana Nethralaya Eye Hospital, Bangalore, India.
Mahalakshmi V RackenchathNarayana Nethralaya Eye Hospital, Bangalore, India.
Sathi Devi A VNarayana Nethralaya Eye Hospital, Bangalore, India.
Suria S MannilNarayana Nethralaya Eye Hospital, Bangalore, India; Byers Eye Institute, Stanford University School of Medicine, Stanford, California.
Sriharsha NagarajNarayana Nethralaya Eye Hospital, Bangalore, India.
Caitlin A MoeFrancis I. Proctor Foundation, University of California, San Francisco, California.
Dionna M WittbergFrancis I. Proctor Foundation, University of California, San Francisco, California.
Kieran S O'BrienFrancis I. Proctor Foundation, University of California, San Francisco, California; Department of Ophthalmology, University of California, San Francisco, California.
Julius T OattsDepartment of Ophthalmology, University of California, San Francisco, California.
Robert L StamperDepartment of Ophthalmology, University of California, San Francisco, California.
Jeremy D KeenanFrancis I. Proctor Foundation, University of California, San Francisco, California; Department of Ophthalmology, University of California, San Francisco, California. Electronic address: jeremy.keenan@ucsf.edu.
University of California, San Francisco · USNarayana Nethralaya · IN

Funding

Village-Integrated Eye Worker trial II (VIEW II)UG1EY028097 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KEENAN, JEREMY DAVID · 2018 to 2023
$2.9M
NEI NIH HHS UG1 EY028097
6 · The paper itself

Abstract

purposePortable perimetric testing could be useful for community-based glaucoma screening programs. Frequency-doubling technology (FDT) and the Moorfields motion displacement test (MDT) are portable perimeters that have shown promise as potential screening tools for glaucoma. This study's goal was to determine the diagnostic accuracy of FDT and MDT for visual field defects and glaucoma.

designProspective, cross-sectional, diagnostic accuracy study.

participantsA consecutive series of patients aged ≥ 50 years who presented to a glaucoma clinic in South India and had never undergone Humphrey field analyzer (HFA) visual field testing in the past.

methodsParticipants underwent 24-2 Swedish Interactive Thresholding Algorithm (SITA) Standard HFA perimetry, FDT perimetry, MDT perimetry, and iPad perimetry using visualFields Easy in random order. Ophthalmologist grades of HFA and optic nerve head photographs were used as reference standards for glaucoma and field defect presence. Receiver operating characteristic curves were constructed to assess the diagnostic accuracy of various parameters for each test.

main outcome measuresSensitivity, specificity, and area under the receiver operating characteristic curve (AUROC).

resultsOverall, 292 eyes from 173 participants were included, with 112 eyes classified as moderate or worse glaucoma. For moderate or worse glaucoma detection, the best parameter on FDT was mean deviation (MD) (AUROC, 0.84; 95% confidence interval [CI], 0.79-0.89) and the best parameter on MDT was global probability of true damage (GPTD) (AUROC, 0.87; 95% CI, 0.82-0.91). When specificity was set to 90%, the sensitivity for detection of moderate or worse glaucoma was 55% (95% CI, 39%-68%) for FDT MD and 62% (95% CI 52%-71%) for MDT GPTD.

conclusionsFrequency-doubling technology and MDT perimetry had fair diagnostic accuracy for glaucoma detection when administered to naïve test takers in this South Indian population. Although not appropriate for use as a sole glaucoma screening test, these perimetric tests may be useful as ancillary tests. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Indexed as

GlaucomaVisual FieldsCross-Sectional StudiesHumansProspective StudiesSensitivity and SpecificityVisual Field TestsFrequency-doubling technology, Glaucoma, Moorfields motion displacement test, Visual fields

Identifiers

PMID36435449
PMCPMC11560139
OpenAlexW4309914095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.